Skip to content

Pavaki Capital Management LLC 13F Holdings · Q2 2026

Pavaki Capital Management LLC reported 132 securities worth $286.82M in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: CVNA (14.23%), QQQ (7.06%), TSLA (6.38%). Among its top 25 positions this quarter: 3 new, 9 added.

RankTickerCompanyValue% PortfolioSharesAction
1CVNACARVANA CO$40.8M14.23%620,000Added
2QQQINVESCO QQQ TR$20.3M7.06%27,500Added
3TSLATESLA MTRS INC$18.3M6.38%43,500Hold
4CVXCHEVRON CORP NEW$16.1M5.61%97,000Added
5MISTMILESTONE PHARMACEUTICALS IN$12.2M4.24%9.1MAdded
6INTUINTUIT$10.1M3.51%38,600New
7QCOMQUALCOMM INC$9.1M3.16%49,000New
8BBARRICK MNG CORP$8.1M2.84%221,500Hold
9TXTTEXTRON INC$7.7M2.70%84,300Added
10PLTRPALANTIR TECHNOLOGIES INC$6.9M2.42%59,500Hold
11REGNREGENERON PHARMACEUTICALS$6.2M2.15%9,900Added
12NVDANVIDIA CORPORATION$5.2M1.81%26,000Added
13ARQTARCUTIS BIOTHERAPEUTICS INC$4.9M1.71%187,000Hold
14SPRYSILVERBACK THERAPEUTICS INC$4.6M1.62%579,600Added
15MUMICRON TECHNOLOGY INC$4.6M1.61%4,000New
16BTGB2GOLD CORP$4.4M1.54%1.2MHold
17LGNDLIGAND PHARMACEUTICALS INC$3.5M1.22%11,100Hold
18APPAPPLOVIN CORP COM$3.2M1.11%6,200Hold
19CGAUCENTERRA GOLD INC$3.1M1.09%197,000Hold
20NEMNEWMONT GOLDCORP CORPORATION$3.0M1.06%32,500Hold
21SLBSCHLUMBERGER LTD$2.8M0.99%61,000Added
22HRMYHARMONY BIOSCIENCES HLDGS IN$2.7M0.93%73,000Hold
23AVGOBROADCOM INC$2.6M0.92%7,000Hold
24RPRXROYALTY PHARMA PLC SHS$2.5M0.86%44,000Hold
25AMDADVANCED MICRO DEVICES INC$2.3M0.81%4,000Hold

Source: SEC Form 13F filings · as of 2026-06-30

Every position in this 13F-HR, with its change from the prior quarter.

13F holdings, latest quarter

SourceSEC EDGAR13F-HR